Target-directed cancer: protein-ligand interactions
Drug Target Review
NOVEMBER 1, 2023
The team that I lead within the CCDD is called the Hit Discovery and Structural Design Team. We support the drug discovery projects of the CCDD with assay development and screening, biophysics, structural biology and recombinant protein production. Capivasertib (orange) bound to the kinase domain of AKT (blue).
Let's personalize your content